Ipratropium/Albuterol Sulfate
Brand name: Combivent Respimat
Rank #151 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$108.3M
Total Cost
353,594
Total Claims
$108.3M
Total Cost
13,193
Prescribers
$306
Cost per Claim
67,069
Beneficiaries
392,314
30-Day Fills
$8,212
Avg Cost/Provider
27
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$108.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $108.3M total
Top Prescribers of Ipratropium/Albuterol Sulfate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 592 | $298K |
| 2 | John Fritz | Family Practice | Jersey City, NJ | 238 | $160K |
| 3 | Sidharth Bagga | Internal Medicine | Oroville, CA | 262 | $155K |
| 4 | Chih Chen | Hospitalist | Springfield, MA | 282 | $150K |
| 5 | Waleed Najeeb | Internal Medicine | Glendale, WI | 161 | $127K |
| 6 | Jay Fleitman | Pulmonary Disease | Northampton, MA | 114 | $123K |
| 7 | Ernesto Mejia | Pulmonary Disease | Morristown, TN | 160 | $113K |
| 8 | Ashok Makadia | Pulmonary Disease | Lorain, OH | 133 | $106K |
| 9 | Xiangsheng Zheng | Internal Medicine | Birmingham, AL | 202 | $105K |
| 10 | Jeffery Neu | Pulmonary Disease | Williamsville, NY | 113 | $98K |
| 11 | Barry Meyer | Internal Medicine | Warren, MI | 186 | $97K |
| 12 | Mohammad Tariq | Pulmonary Disease | Kokomo, IN | 118 | $97K |
| 13 | Stephen Chen | Critical Care (Intensivists) | Monterey Park, CA | 170 | $91K |
| 14 | Alan Nili | Family Practice | Irvine, CA | 60 | $90K |
| 15 | Muhammad Ehtisham | Pulmonary Disease | Pawtucket, RI | 153 | $83K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 148 | Immun Glob G(Igg)/Gly/Iga 0-50 (Gammaplex) | $109.6M | 7,815 |
| 149 | Mesalamine (Mesalamine) | $109.3M | 176,079 |
| 150 | Axitinib (Inlyta) | $109.1M | 5,937 |
| 151 | Ipratropium/Albuterol Sulfate (Combivent Respimat) | $108.3M | 353,594 |
| 152 | Relugolix (Orgovyx) | $107.3M | 38,821 |
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
| 154 | Divalproex Sodium (Divalproex Sodium) | $103.4M | 1,921,840 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology